S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PHIO Phio Pharmaceuticals Corporation

1.90

-0.07 (-3.55%)

07 Jan 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Phio Pharmaceuticals (NASDAQ:PHIO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Phio Pharmaceuticals Charts.

Phio Pharmaceuticals (NASDAQ:PHIO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Phio Pharmaceuticals Charts.

Phio Pharmaceuticals Corporation News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 28 December 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Friday 27 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 24 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 21 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Saturday 21 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 20 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 14 September 2024 (4 months ago) • Edgar (US Regulatory)

More Phio Pharmaceuticals Corporation News Articles

World Bank Green Bond Zc...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions